Literature DB >> 12629134

Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls.

Gabriela Guercio1, Marco A Rivarola, Eduardo Chaler, Mercedes Maceiras, Alicia Belgorosky.   

Abstract

The aim of this study was to analyze the possible implication of changes in the GH/IGF-I axis and in insulin sensitivity for the regulation of adrenal androgen secretion of normal prepubertal and adolescent girls. A total of 61 normal girls were evaluated in prepuberty [Group (Gr)1, n = 33; early (Gr1A, n = 16) and late (Gr1B, n = 17)]; puberty (Gr3, n = 28), early (Gr3A, n = 9) and late (Gr3B, n = 19); and during the transition between prepuberty and puberty (Gr2, n = 26). Insulin sensitivity was estimated by the fasting glucose/insulin ratio (G/I). In Gr1, G/I was significantly higher, and the mean serum IGF-I and serum dehydroepiandrosterone sulfate (DHEAS) were significantly lower than in Gr3 (P < 0.0001). Mean G/I in Gr1A and Gr3A was significantly higher than in Gr1B (P < 0.01) and Gr3B (P < 0.02), respectively, and ratios in Gr1B were also significantly higher than in Gr3A (P < 0.02). However, body mass index (BMI) in Gr1A, Gr1B, and Gr3A was not significantly different, although a significant increment was observed between late prepuberty (Gr1B) and late puberty (Gr3B; P < 0.0001). On the other hand, serum IGF-I levels in Gr1A and Gr3A were significantly lower than those in Gr1B (P < 0.01) and Gr3B (P < 0.02), respectively. The mean serum DHEAS level in Gr1A and Gr3A was significantly lower than in Gr1B (P < 0.01) and Gr3B (P < 0.02), respectively, and the level in Gr1B was also significantly lower than in Gr3A (P < 0.02). Correlation studies within Gr1, Gr2, and Gr3 were also performed. There was a significant positive correlation between serum DHEAS and age and a significant negative correlation between serum DHEAS and G/I in the three groups. However, a significant positive correlation between serum DHEAS and serum IGF-I was only found in Gr1. Furthermore, a significant negative correlation between BMI and the G/I was found in Gr2 and Gr3. Therefore, changes in insulin sensitivity might be involved in adrenal androgen synthesis both in prepuberty and in puberty, as well as during the transition from prepuberty to puberty. Changes in BMI suggest that adiposity might be a mediator of this effect, particularly during late puberty. On the other hand, the GH/IGF axis might be an important metabolic signal involved in the maturational changes of human adrenal androgens during prepuberty, at the time of adrenarche. Indeed, a significant negative correlation between G/I and serum IGF-I was found in Gr1, as well as in Gr2. In conclusion, the findings of this study indicate that the GH/IGF-I axis and insulin resistance might be involved in the mechanism of adrenarche during prepuberty in normal girls. Because these relationships had not been seen in boys, we proposed that prepubertal ovarian estrogens might be responsible for the sex difference. The relationship between insulin resistance and adrenal androgens persists during the transition from prepuberty to puberty, as well as during puberty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629134     DOI: 10.1210/jc.2002-020979

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Contributors to Pediatric Obesity in Adolescence: More than just Energy Imbalance.

Authors:  Michelle Cardel; Akilah Dulin-Keita; Krista Casazza
Journal:  Open Obes J       Date:  2011

2.  Prenatal caffeine exposure-induced adrenal developmental abnormality in male offspring rats and its possible intrauterine programming mechanisms.

Authors:  Zheng He; Chunyan Zhu; Hegui Huang; Lian Liu; Linlong Wang; Liaobin Chen; Jacques Magdalou; Hui Wang
Journal:  Toxicol Res (Camb)       Date:  2016-01-15       Impact factor: 3.524

Review 3.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 4.  Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche.

Authors:  Alicia Belgorosky; María Sonia Baquedano; Gabriela Guercio; Marco A Rivarola
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

Review 5.  Etiology of insulin resistance in youth with type 2 diabetes.

Authors:  Melanie Cree-Green; Taylor M Triolo; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

Review 6.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

7.  Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26).

Authors:  Alison N Jeffery; Brad S Metcalf; Joanne Hosking; Adam J Streeter; Linda D Voss; Terence J Wilkin
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

8.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

9.  Associations of lifestyle factors with serum dehydroepiandrosterone sulphate and insulin-like growth factor-1 concentration in prepubertal children.

Authors:  Aino Mäntyselkä; Jarmo Jääskeläinen; Aino-Maija Eloranta; Juuso Väistö; Raimo Voutilainen; Ken Ong; Søren Brage; Timo A Lakka; Virpi Lindi
Journal:  Clin Endocrinol (Oxf)       Date:  2017-11-29       Impact factor: 3.478

10.  Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight.

Authors:  Camila Corvalán; Ricardo Uauy; Verónica Mericq
Journal:  Am J Clin Nutr       Date:  2013-01-02       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.